H&R Block (HRB) Q1 Earnings Beat Estimates, Improve Y/Y
H&R Block, Inc. HRB reported better-than-expected first-quarter fiscal 2021 results.
Adjusted earnings per share of 55 cents beat the Zacks Consensus Estimate by 48.7%. The company had suffered a loss of 72 cents per share in the year-ago quarter. Revenues of $601 million surpassed the consensus estimate by 7.7% and increased more than 100% year over year.
This significant year-over-year improvement in both the top and bottom lines is due to the extended tax season in response to the coronavirus pandemic. The deadline for Federal filing was extended to Jul 15.
Shares of H&R Block have declined 39.7% over the past year compared with the 14.6% rally of the Zacks S&P 500 composite.
Other Quarterly Numbers
Earnings before interest, tax, depreciation and amortization from continuing operations came in at $195.7 million compared with a loss of $147.4 million in the year-ago quarter. Adjusted EBITDA margin from continuous operations came in at 32.6% in the quarter. Total operating expenses were $448.1 million, up 29.7% year over year.
H&R Block exited the quarter with cash and cash equivalents balance of $2.6 billion compared with $2.7 billion at the end of the prior quarter. Long-term debt and line-of-credit borrowings were $3.5 billion compared with $2.8 billion at the end of the previous quarter.
The company used $20.5 million of cash in operating activities and capex was $8.3 million. The company paid out dividends of $50 million in the quarter.
H&R Block currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Recent Performance of Some Services Companies
Equifax EFX reported second-quarter 2020 adjusted earnings of $1.60 per share, which beat the Zacks Consensus Estimate by 22.1% and improved 14.3% on a year-over-year basis. Revenues of $982.8 million outpaced the consensus estimate by 6.4% and improved 12% year over year.
TransUnion TRU reported second-quarter 2020 adjusted earnings of 66 cents per share that outpaced the consensus mark by 34.7% but declined 4.3% year over year. Total revenues of $634 million beat the consensus mark by 6.2% but decreased 4% year over year.
Rollins, Inc.’s ROL reported second-quarter 2020 adjusted earnings of 23 cents per share beating the consensus mark by 35.3% and increasing 9.5% year over year. Revenues of $553.3 million beat the consensus mark by 2.2% and improved 5.6% year over year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Equifax, Inc. (EFX) : Free Stock Analysis Report
HR Block, Inc. (HRB) : Free Stock Analysis Report
Rollins, Inc. (ROL) : Free Stock Analysis Report
TransUnion (TRU) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
